SAM.gov listing
Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV
- Agency
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF.NATIONAL INSTITUTES OF HEALTH.NATIONAL INSTITUTES OF HEALTH NIDA
- NAICS
- 541690
- Set-aside
- No Set aside used
- Type
- Combined Synopsis/Solicitation
- CaptureIQ category
- Other
- Response deadline
- 2026-07-30T09:00:00-04:00
Related Federal Opportunities
- Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional) · National Institutes of Health · due Oct 19, 20
- PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional) · National Institutes of Health · due Oct 19, 20
- NIH Director’s Transformative Research Award for Individual and Group Science (R01 Clinical Trial Optional) · National Institutes of Health · due Sep 03, 20